Source link : https://www.newshealth.biz/health-news/cetuximab-plus-rt-benefits-some-with-head-and-neck-cancer/
TOPLINE: Adding cetuximab (C) to postoperative radiotherapy (RT) improves disease-free survival (DFS) but not overall survival (OS) in intermediate-risk squamous cell carcinoma of the head and neck. Benefits were specifically observed in human papillomavirus–negative patients, who represented 80.2% of the study participants. METHODOLOGY: Previous research showed that adding high-dose cisplatin to postoperative RT in patients […]
Author : News Health
Publish date : 2025-01-30 12:47:55
Copyright for syndicated content belongs to the linked Source.